Our site uses cookies necessary for its proper functioning. To improve your experience, other cookies may be used: you can choose to disable them. This can be changed at any time via the Cookies link at the bottom of the page.

TALISMENT : Diagnosis, Prevention and Treatment of Neurological, Psychiatric, Metabolic and Sleep Disorders

Scientific coordinator : Dr. Erwan Bezard

Last update Thursday 11 February 2016
Scientific coordinator : Dr. Erwan Bezard

Dr. Erwan Bezard, INSERM Research Director, is head of the Institute of Neurodegenerative Diseases (IMN). He has authored or co-authored over 200 professional publications in the field of neurobiology, most of which are on Parkinson's disease and related disorders. Listed in the Top 1% of the most cited neuroscientists, he is best known for his work on the compensatory mechanisms that mask the progression of Parkinson's disease and on the pathophysiology of levodopa-induced dyskinesia. His current research interests include the study of levodopa-induced dyskinesia, the intimate mechanisms of cell death in Parkinson’s disease, the modeling of disease progression and the development of new strategies to alleviate symptoms and/or to slow disease progression.